Recently, China’s first company dedicated to ultrasound-based brain-computer interface (BCI) technology was officially established, marking a significant step forward in the nation’s development of non-invasive BCI solutions. Named ‘Lingxi NeuroTech,’ the company is headquartered in Beijing’s Zhongguancun Science Park and features a core team of experts in neural engineering and artificial intelligence from Tsinghua University, the Chinese Academy of Sciences, and top international universities. Unlike conventional electroencephalography (EEG)-based or invasive implant approaches, Lingxi NeuroTech employs high-resolution functional ultrasound (fUS) to non-invasively monitor deep brain activity through the skull, offering superior spatial resolution and enhanced safety. This ultrasound BCI approach eliminates the risks associated with craniotomy while enabling precise monitoring and modulation of specific brain regions, holding immense potential in medical rehabilitation, mental health interventions, and human-computer interaction. The company has already secured seed funding and initiated clinical collaborations with several top-tier hospitals. Industry experts believe this move could accelerate China’s independent innovation in next-generation BCI technologies and strengthen its position in the global neurotechnology landscape.
近日，中国首家专注于超声波脑机接口技术的企业正式成立，标志着我国在非侵入式脑机接口领域迈出关键一步。该企业名为‘灵犀智联’，总部位于北京中关村科技园区，核心团队由来自清华大学、中科院及海外顶尖高校的神经工程与人工智能专家组成。与传统的基于电极的脑电图（EEG）或侵入式植入技术不同，该公司采用高分辨率聚焦超声波（fUS）技术，通过颅骨无创地探测大脑深层神经活动，具有更高的空间分辨率和安全性。超声波脑机接口不仅避免了开颅手术风险，还能实现对特定脑区的精准监测与调控，在医疗康复、精神疾病干预、人机交互等领域具有广阔应用前景。公司目前已完成天使轮融资，并与多家三甲医院达成临床合作意向。业内专家认为，此举有望加速中国在下一代脑机接口技术上的自主创新，推动‘中国智造’在全球神经科技赛道中占据一席之地。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/8956.html